CODS Journal of Dentistry
Volume 13 | Issue 1 | Year 2021

Oral Cancer Prevention Strategies: A Great Deal Remains to be Done

Mellekatte C Neetha1

Department of Oral Medicine and Radiology, College of Dental Sciences, Davangere, Karnataka, India

Corresponding Author: Mellekatte C Neetha, Department of Oral Medicine and Radiology, College of Dental Sciences, Davangere, Karnataka, India, Phone: +91 9900207778, e-mail: neethamc@gmail.com

How to cite this article: Neetha MC, Oral Cancer Prevention Strategies: A Great Deal Remains to be Done. CODS J Dent 2021;13(1):1–2.

Source of support: Nil

Conflict of interest: None


Oral cancer is a global challenge, with a high degree of mortality ~50%.1 Oral cancer is graded as the sixth most widespread malignancy in South Asia–with approximately 300,000 recent cases identified annually, accounting for one-third of the overall cancer burden in India.2 The key risk factors linked with oral cancer are tobacco use and alcohol consumption, having a dose-response association, and synergistic effect.3 Other trivial factors being UV /sunlight, diet and nutritional status, chronic candidal infection, Human papilloma virus [HPV], Herpes simplex virus, Hepatitis-C virus, Epstein-Barr Virus, and immune deficiency.4,5

In spite of effortless access to examination, oral cancers presentation is delayed with devastating consequences on survival and quality of life.1 Hence the chief goal should be to emphasis on preventive measures so that mortality due to oral cancer is diminished and is in control.


Cancer Prevention StrategiesCancer prevention strategies can be charted into three stages:

To summarize oral cancer prevention strategies, include oral screening, exposure modification [tobacco cessation], cancer immunotherapy/vaccination, chemoprevention, treatment or removal of PMDs, risk-reducing surgery to remove tissue at risk, and screening and early-detection methods based on molecular biomarkers. All these will certainly lead to valuable strategies to reduce the incidence, morbidity and mortality of oral cancers in the near future.


1. D’Cruz AK, Vaish R. Risk-based oral cancer screening - lessons to be learnt. Nat Rev Clin Oncol 2021;18(08):471–472. DOI: 10.1038/s41571-021-00511-2

2. Seenan P, Conway D. Smokeless tobacco - a substantial risk for oral potentially malignant disorders in South Asia. Evid Based Dent. 2017;18(02):54-55. DOI: 10.1038/sj.ebd.6401242. PMID: 28642557.

3. Ogden GR, Macluskey M. An overview of the prevention of oral cancer and diagnostic markers of malignant change: 1. Prevention. Dent Update 2000;27(02):95–99. DOI: 10.12968/denu.2000.27.2.95. PMID: 11218278.

4. D’souza S, Addepalli V. Preventive measures in oral cancer: an overview. Biomed Pharmacother 2018;107:72-80. DOI: 10.1016/j.biopha.2018.07.114. Epub 2018. PMID: 30081204.

5. Lippman SM, Sudbø J, Hong WK. Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 2005;23(02):346–356. DOI: 10.1200/JCO.2005.09.128

6. Meyskens FL Jr, Mukhtar H, Rock CL, et al. Cancer prevention: obstacles, challenges and the road ahead J Natl Cancer Inst 2015;108(02):djv309. DOI: 10.1093/jnci/djv309. PMID: 26547931; PMCID: PMC4907357.

7. Schüz J, Espina C, Wild CP. Primary prevention: a need for concerted action. Mol Oncol 2019;13(03):567–578. DOI: 10.1002/1878-0261.12432. Epub 2019. PMID: 30582778 PMCID: PMC6396360.

8. Foy JP, Bertolus C, William WN Jr, et al. Oral premalignancy: the roles of early detection and chemoprevention. Otolaryngol Clin North Am 2013;46(04):579–597. DOI: 10.1016/j.otc.2013.04.010. Epub 2013. PMID: 23910471; PMCID: PMC3734384.

9. Neetha MC, Panchaksharappa MG, Pattabhiramasastry S, et al. Chemopreventive synergism between green tea extract and curcumin in patients with potentially malignant oorders: a double-blind, randomized preliminary study. Contemp Dent Pract 2020;21(05):521–531. DOI: 10.5005/jp-journals-10024-2823. PMID: 32690834.

10. Dunn BK, Greenwald P. Cancer prevention I: introduction. Semin Oncol 2010;37(03):190–201. DOI: 10.1053/j.seminoncol.2010.06.011. PMID: 20709204.

11. Maresso KC, Tsai KY, Brown PH, et al. Molecular cancer prevention: current status and future directions. CA Cancer J Clin 2015;65(05):345–383. DOI: 10.3322/caac.21287. Epub 2015. PMID: 26284997; PMCID: PMC4820069.

12. Miao L, Zhang Y, Huang L. mRNA vaccine for cancer immunotherapy. Mol Cancer 2021;20(01):41. DOI: 10.1186/s12943-021-01335-5. PMID: 33632261; PMCID: PMC7905014.

© The Author(s). 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.